We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Expediting the FDA Generic Drug Approval Process
Expediting the FDA Generic Drug Approval Process
September 14, 2015
The steady growth over the past decade in abbreviated new drug applications (ANDAs) from both domestic and foreign generic drug manufacturers has led to a backlog of applications at the FDA. It now takes the agency on average about three years to review and approve a typi-cal ANDA.